激活诱导的cytidine去氨酶显示了一个替代的辅助因子,用于调节PIM1表达在扩散的大B细胞淋巴瘤细胞系中的PIM1表达
Yang Wang1, Yinsha Miao2, Wen Zhou3
1Department of Pathogenic Biology and Immunology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Centre, Xi'an, Shaanxi, China. yang3118115021@stu.xjtu.edu.cn.
Cellular and molecular biology (Noisy-le-Grand, France)
|June 10, 2023
概括
激活诱导的cytidine去氨酶 (AID) 调节在扩散大B细胞淋巴瘤 (DLBCL) 中的PIM1表达. 艾滋病与DNMT1或TET2相互作用,影响PIM1水平和DLBCL细胞增殖,揭示了艾滋病的新角色.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 扩散性大B细胞淋巴瘤 (DLBCL) 的特点是高PIM1表达,与预后不佳相关.
- 激活诱导的cytidine除氨酶 (AID) 涉及DLBCL中的PIM1高突变.
研究的目的:
- 调查激活诱导的cytidine deaminase (AID) 在调节DLBCL中的PIM1表达中的作用.
- 探索AID与DLBCL病变发生过程中的DNA甲基化和脱甲基化因子的相互作用.
主要方法:
- 利用DLBCL细胞系 (SU-DHL-4和OCI-LY7) 来研究基因表达变化.
- 通过枯竭和过度表达操纵了AID,DNMT1和TET2水平.
- 评估了PIM1表达和DLBCL细胞增殖率.
主要成果:
- 艾滋病消耗降低了DNA甲基转移酶1 (DNMT1) 水平,增加了PIM1的表达,加速了DLBCL的扩散.
- 艾滋病过度表达增加了DNMT1水平,而艾滋病缺陷降低了11个转位家族成员2 (TET2) 水平.
- 双重耗尽AID和TET2降低了PIM1水平并减缓了细胞分裂,这表明AID在PIM1.1表观遗传调节中的作用.
结论:
- 激活诱导的氨酸脱胺酶 (AID) 与DNMT1或TET2一起作为辅助因子,调节DLBCL中的PIM1表达.
- 艾滋病与DNMT1或TET2的相互作用影响PIM1促进体活性,影响DLBCL细胞增殖.
- 这些发现阐明了DLBCL相关基因中AID的新型表观遗传调节作用.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
B Cell Activation and Differentiation
1.8K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.8K
Negative Regulator Molecules
35.5K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.5K


